Antimicrobial Susceptibilities of Clinical Isolates of HACEK Organisms
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The “HACEK” organisms are a group of fastidious Gram-negative bacteria that cause a variety of infections, including infective endocarditis. Antimicrobial susceptibility testing is not universally available, and therapy for these infections is often empirical. We report the antimicrobial susceptibilities of 70 clinical HACEK isolates to 18 antimicrobials. All isolates were susceptible to ceftriaxone and levofloxacin, indicating that these agents remain appropriate empirical choices for the treatment of infections with this group of organisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, β-lactamaseproducing strains of HACEK are appearing with increased frequency; rarely, resistance to ampicillin can occur in β-lactamase-negative strains.219”
From Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association (2015) · cites this paper as [219]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In 1 survey, 60% of isolates did not grow adequately in control wells, and no valid in vitro susceptibility results were available.219”
The cited source says what the claim attributes to it.
In the citing paper
“In addition, ampicillin-sulbactam may be considered a treatment option, although HACEK resistance to this agent in vitro has been described.219”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical and Laboratory Standards Institute
(2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,091
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Jorgensen, J. H., & Clinical (2006) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,047
Gould, F. K., Denning, D. W., Elliott, T. S. J., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., & Watkin, R. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr450 · Cited by 593
Gould, F. K. (2012) · Journal of Antimicrobial Chemotherapy · Cited by 193
Sheng, W.-S., Hsueh, P., Hung, C., Teng, L., Chen, Y., & Luh, K. T. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/pl00011259 · Cited by 84
Yagupsky, P., Katz, O., & Peled, N. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.2.191 · Cited by 80
Kugler, K. C., Biedenbach, D. J., & Jones, R. N. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00165-5 · Cited by 68 · cited 1×
“To our knowledge, only one study has described the antimicrobial susceptibilities of multiple genera of HACEK organisms, which included 42 clinical and American Type Culture Collection (ATCC) strains (4).”
Background16S Ribosomal DNA Typing for Identification of Pathogens in Patients with Bacterial Keratitis
Knox, C., Cevellos, V., & Dean, D. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.12.3492-3496.1998 · Cited by 56 · cited 1×
“Isolates were identified using either traditional biochemical tests or the 16S rRNA molecular assay (5).”
Method
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“In 1 survey, 60% of isolates did not grow adequately in control wells, and no valid in vitro susceptibility results were available.(219) Therefore, unless growth is adequate for in vitro screening, then HACEK microorganisms should be considered ampicillin resistant, and penicillin and ampicillin should not be used to…”
BackgroundInfluentialHolland, T. L., Baddour, L. M., Bayer, A. S., Hoen, B., Miro, J. M., & Fowler, V. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.59 · Cited by 406
JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis
Nakatani, S., Ohara, T., Ashihara, K., Izumi, C., Iwanaga, S., Eishi, K., Okita, Y., Daimon, M., Kimura, T., Toyoda, K., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0549 · Cited by 179
HACEK endocarditis: state-of-the-art
Revest, M., Egmann, G., Cattoir, V., & Tattevin, P. (2016) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2016.1164032 · Cited by 140
“aphrophilus found susceptibility rates of 82% for penicillin, and 100% for ampicillin, amoxicillin-clavulanic acid, ceftriaxone, meropenem, and levofloxacin [19].”
BackgroundInfluentialInfective endocarditis by HACEK: a review
Khaledi, M., Sameni, F., Afkhami, H., Hemmati, J., Dezfuli, A. A. Z., Sanae, M.-J., & Validi, M. (2022) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-022-01932-5 · Cited by 134
“HACEK microorganisms cause disease such as periodontal infections, bacteremia, endocarditis, and polymicrobial wound infections [36] otitis media, and abscesses [36, 42, 43].”
BackgroundHuman and Other Mammalian Bite Injuries of the Hand: Evaluation and Management
Kennedy, S. A., Stoll, L. E., & Lauder, A. S. (2014) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-23-01-47 · Cited by 104
Sharara, S. L., Tayyar, R., Kanafani, Z. A., & Kanj, S. S. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1184085 · Cited by 78
“susceptibilities of 241 HACEK isolates in Ontario, Canada confirmed the difficult susceptibility testing and the high resistance among HACEK microorganisms [3].”
BackgroundMethodInfluentialInfectious endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021
Демин, А. А., Kobalava, Z. D., Skopin, I. I., Tyurin, P. V., Boytsov, S. A., Golukhova, E. Z., Гордеев, М. Л., Gudymovich, V. D., Demchenko, E. A., Дробышева, В. П., et al. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-5233 · Cited by 69
A review of current treatment strategies for infective endocarditis
Paz, D. L., Lakbar, I., & Tattevin, P. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1822165 · Cited by 43
“facts: the emergence of beta-lactamase-producing strains into the HACEK group, and the difficulty to obtain reliable drugsusceptibility testing, in nearly 60% of the cases, for these slow-growing species [80,81].”
BackgroundGarg, A., Gupta, A., Mishra, A., Singh, M. K., Yadav, S., & Nityanand, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209832 · Cited by 33
Eikenella corrodens endocarditis and liver abscess in a previously healthy male, a case report
Nordholm, A. C., Vøgg, R. O. B., Permin, H., & Katzenstein, T. L. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-2949-4 · Cited by 20
Bernard, K. A., Burdz, T., Wiebe, D. J., & Bernier, A.-M. (2020) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.004150 · Cited by 19
Gram-negative endocarditis: disease presentation, diagnosis and treatment.
Bouza, E., Muñóz, P., & Burillo, A. (2021) · PubMed · doi:10.1097/qco.0000000000000788 · Cited by 17
Current Evidence on Oral Antibiotics for Infective Endocarditis: A Narrative Review
Kobayashi, T., Ando, T., Streit, J. A., & Sekar, P. (2019) · Cardiology and Therapy · doi:10.1007/s40119-019-00148-4 · Cited by 12
Maeda, K., Hirai, Y., Nashi, M., Yamamoto, S., Taniike, N., & Takenobu, T. (2021) · Journal of Dental Sciences · doi:10.1016/j.jds.2021.09.023 · Cited by 12
“Nakano et al. reported that more than 90% of dentists recognize the importance of prophylaxis for IE.35 However, the JCS guidelines recommend the administration of amoxicillin 2 g or 30 mg/kg before an invasive procedure in adults, whereas the Japanese Society of Chemotherapy recommends 500 mg of amoxicillin.”
BackgroundInfluentialRoth, B., Schimke, K. E., Ruckstuhl, A., Külling, F., Dietrich, T. J., & Strahm, C. (2019) · Case Reports in Infectious Diseases · doi:10.1155/2019/7620186 · Cited by 11
Kobayashi, T., Arshava, E. V., Ford, B. A., & Sekar, P. (2019) · BMJ Case Reports · doi:10.1136/bcr-2019-230287 · Cited by 11
Sumer, J., Haller, S., Sawatzki, M., Kellner, J., & Boggian, K. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-020-02650-z · Cited by 9
“Resistance to ampicillin with beta-lactamase production has infrequently been reported for Aggregatibacter and Haemophilus [20, 21].”
BackgroundUnique presentation of Aggregatibacter aphrophilus in a superficial left temporal abscess
Moreno, T., Varman, R. M., & Idicula, W. K. (2020) · IDCases · doi:10.1016/j.idcr.2020.e00753 · Cited by 7
“Broad-spectrum cephalosporins and fluoroquinolones are most commonly used for antimicrobial treatment of HACEK organisms based on past reports and proved to eliminate this patient’s infection and support the use of these antimicrobials for future cases [11].”
BackgroundJCS 2026 Guideline on the Management of Infective Endocarditis
Izumi, C., Daimon, M., Kaji, S., Masumoto, A., Ashihara, K., Amano, M., Uemura, S., Ota, H., Ohara, T., Okada, K., et al. (2026) · Circulation Journal · doi:10.1253/circj.cj-25-0987 · Cited by 7
Eikenella Corrodens Vertebral Osteomyelitis in a Young Patient With Type I Diabetes Mellitus
Ranabhat, K., Bhatta, S., Bhatta, R. K., & Acharya, Y. (2020) · Cureus · doi:10.7759/cureus.9553 · Cited by 6
Susceptibility Test Methods: Fastidious Bacteria
Humphries, R. M., & Bard, J. D. (2015) · ClinMicroNow · doi:10.1002/9781683670438.mcm0077.pub2 · Cited by 6
Hadvani, T., & Dutta, A. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002513 · Cited by 5
Aggregatibacter aphrophilus aortic valve infective endocarditis
Broa, A. L., Cruz, I. R., Cotrim, C., & Diogo, J. (2016) · Infectio · doi:10.22354/in.v21i2.656 · Cited by 3
The first case of cholecytitis caused by Aggregatibacter kilianii in Korea
Yang, D., Kim, C., Park, J., Song, N. Y., Lee, Y., & Lee, W. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07471-7 · Cited by 3
“Also, since a β-lactamaseproducing strain of the HACEK group was reported, the results were very important in the treatment of this bacterium [7].”
ResultHaemophilus aphrophilus and Eikenella corrodens Coinfection of Brain: An Unusual Case from China
Liu, Y., Lai, L. M., Zhu, X., Zhao, R., Yuan, L., & Chen, Q. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s458020 · Cited by 3
Kingella kingae Prosthetic Valve Endocarditis: Report of a Case and Review of the Literature
Patel, A. P., Bishburg, E., Nagarakanti, S., & Cohen, M. C. (2013) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000123 · Cited by 3
“K kingae is susceptible to A-lactams, macrolides, tetracyclines, cotrimoxazole, and quinolones.(7) Recently, a few reports of A-lactamase producing isolates have been published.”
BackgroundInfective endocarditis caused by gram-negative bacteria
Чипигина, Н. С., Karpova, N. Y., Kashentseva, N. A., & Morits, V. (2022) · The Clinician · doi:10.17650/1818-8338-2021-15-1-4-k651 · Cited by 2
“Но так как в последнее время чаще выявляются штаммы, продуцирующие бета-лактамазу, а кроме того, резистентность к ампициллину возможна и при отсутствии бета-лактамазной активности [50], ампициллин не рассматривается более как антибиотик 1-й линии для лечения НАСЕК ИЭ, хотя рандомизированных контролируемых испытаний ам…”
Bae, S., Lee, S. J., Kim, Y. K., Moon, H., Cho, K. R., & Lee, R. (2023) · Pediatric Infection & Vaccine · doi:10.14776/piv.2023.30.e16 · Cited by 2
Oral amoxicillin/clavulanate for the prevention of bacteremia following dental extractions
Freitas, M. D., Álvarez-Fernández, M., Vidal, F. J. V., Posse, J. L., Dios, P. D., & Feijoo, J. F. (2022) · Oral Diseases · doi:10.1111/odi.14221 · Cited by 2
Haemophilus influenzae endocarditis: a case report and literature review
Jaafar, N., Duddu, A., Guru, S., & Oni, I. (2024) · Infection · doi:10.1007/s15010-024-02219-8 · Cited by 1
“It is noteworthy that HI is not included in the HACEK group due to its rare involvement in endocarditis [4, 5].”
Atypical presentation of right-sided native valve infective endocarditis
Doyle, D., Lang, R., & Larios, O. E. (2021) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2020-0033 · Cited by 1
2025 Clinical practice guidelines for Infectious endocarditis and infection of intracardiac devices
Кобалава, Ж. Д., Демин, А. А., Titov, D. A., Kozlov, R. S., Artyukhina, Е. А., Boytsov, S. A., Golukhova, E. Z., Гордеев, М. Л., Gudymovich, V. D., А., Д. Е., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2026-6853 · Cited by 1
Weitere medizinisch bedeutsame Bakterien
Hornef, M. (2012) · Springer-Lehrbuch · doi:10.1007/978-3-642-24167-3_50 · Cited by 1
Sasaki, M., Ishikawa, T., Shimoyama, Y., Kodama, Y., Tajika, S., & Kimura, S. (2018) · Research Journal of Microbiology · doi:10.3923/jm.2018.93.99 · Cited by 1
HACEK organisms exhibit low minimum inhibitory concentrations to ertapenem
Pence, M. A., & Burnham, C. D. (2015) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2015.03.004
Infecciones por otros bacilos Gram negativos: grupo HACEK
Leiva, J., Reina, G., Fernández-Alonso, M., & del Pozo, J. L. (2018) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2018.02.013
Williams, I. (2014) · Morecambe Bay medical journal · doi:10.48037/mbmj.v7i3.164
Weitere medizinisch bedeutsame Bakterien
Hornef, M. W. (2016) · Springer-Lehrbuch · doi:10.1007/978-3-662-48678-8_50
Chu, V. H. Y. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139855952.156
AGGREGATIBACTER APHROPHILUS AS A RARE CAUSE OF ENDOGENOUS ENDOPHTHALMITIS
Kanda, P., Kundapur, D., Chen, H., & Dollin, M. L. (2024) · Retinal Cases & Brief Reports · doi:10.1097/icb.0000000000001604
Susceptibility Test Methods: Fastidious Bacteria
Humphries, R. M., & Bard, J. D. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0077
Susceptibility Test Methods: Fastidious Bacteria
Humphries, R. M., & Bard, J. D. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0077
Dündar, T., Habip, Z., Koçoğlu, E., & Özekinci, T. (2025) · Medeniyet Medical Journal · doi:10.4274/mmj.galenos.2025.69327
Cai, Z., Deng, M., Sun, Y., Yu, M., Yan, Q., Liu, Y., & Li, K. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-12921-7
“Although older reports suggested broad β-lactam susceptibility [14], β-lactamase-associated penicillin/ampicillin non-sus-ceptibility has been documented [15].”
ENDOCARDITIS CAUSED BY HACEK GROUP MICROORGANISMS
Svishcheva, M. V., Сидняев, В. А., Kuznetsova, M. A., Pechatkin, M. M., & Vardov, K. V. (2025) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2025-14-6-249-258
Infecciones por microorganismos del grupo HACEK y otros bacilos gramnegativos infrecuentes
Martínez, M. M. (2026) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2026.04.003
Co, D. G., Misra, T., Lin, L., Mok, M., Mina, N., Kadhim, T., & Losie, J. A. (2026) · Access Microbiology · doi:10.1099/acmi.0.001248.v3
“HACEK organisms have been increasingly resistant to ampicillin [3, 19].”
ndiwah, S. E., Abraham, E., & smith, E. (2026) · Research Square · doi:10.21203/rs.3.rs-10460124/v1
Saleh, S. M., Manohar, T., Azzam, R., & Sabunwala, S. (2026) · Cureus · doi:10.7759/cureus.118017
Metadata
- Authors
- Coburn, B., Toye, B., Rawte, P., Jamieson, F. B., Farrell, D. J., & Patel, S. N.
- Affiliations
- University of Toronto (CA)
- University of Ottawa (CA)
- Public Health Ontario (CA)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2013-04
- Volume
- 57
- Issue
- 4
- Pages
- 1989-1991
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3623346
- OpenAlex
- W2102466313
- Semantic Scholar
- 3ae6fc88689befddd94564706405cc7b131253e8
- Cited by
- 50
- References
- 10
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 5 · 2018: 4 · 2016: 5 · 2015: 4 · 2014: 2 · 2013: 1
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antimicrobial susceptibility, infective endocarditis, empirical antibiotic therapy, ceftriaxone, levofloxacin, clinical isolates
- MeSH terms
- Anti-Bacterial Agents, Ceftriaxone, Gram-Negative Bacteria, Microbial Sensitivity Tests, Ofloxacin, Levofloxacin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.